Mark R. Anderson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark R. Anderson has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Dennis G. Peters
4 shared publicationsHarry C. Dorn
Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060-0212, and Bruker BioSpin Corporation, Billerica, Massachusetts 01821
4 shared publicationsStanley Pons
4 shared publicationsStephanie E. Hooper
Methodist University, Department of Chemistry, 5400 Ramsey St., Fayetteville, NC 28311, USA
4 shared publicationsWesley Sanders
Department of Chemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA 24060-0212, United States
4 shared publications- Daniel John Blackwood
Department of Materials Science & Engineering, National University of Singapore, Singapore, Singapore
3 shared publications
Latest Publications
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 11 (5) , 623-627
Recurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis—A Case Report
- 1 September 2021
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 11 (5) , 623-627
Open AccessRecurrent Pyroglutamic Acidosis in the Context of Undiagnosed Liver Cirrhosis—A Case Report
- Open Access
- 11 September 2020
- Published by American Society for Engineering Education
- p. 25.39.1-25.39.11
A Design-by-Analysis Project for Introductory Students in Aerospace Engineering
- 11 September 2020
- Published by American Society for Engineering Education
- p. 25.39.1-25.39.11
Open AccessA Design-by-Analysis Project for Introductory Students in Aerospace Engineering
- Open Access
- 4 September 2020
- Published by American Society for Engineering Education
- p. 23.1028.1-23.1028.13
Redmine as a Web-Based Collaboration Tool in Engineering Design Courses
- 4 September 2020
- Published by American Society for Engineering Education
- p. 23.1028.1-23.1028.13
Open AccessRedmine as a Web-Based Collaboration Tool in Engineering Design Courses
- Open Access
- 28 August 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Spectrum
- Vol. 56 (09) , 10-11
U.S. airline orders first passenger electric plane: The battery-powered nine-seater aircraft will enter service in 2022 - [News]
Electric aviation took a big step forward in June when a Massachusetts-based airline announced it had placed the world's first order for a commercial all-electric passenger airplane. The Alice, a three-engine, battery-powered airplane that can fly up to 1,000 kilometers on a single charge, will be delivered to Cape Air in 2022.
- 28 August 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Spectrum
- Vol. 56 (09) , 10-11
Open AccessU.S. airline orders first passenger electric plane: The battery-powered nine-seater aircraft will enter service in 2022 - [News]
Electric aviation took a big step forward in June when a Massachusetts-based airline announced it had placed the world's first order for a commercial all-electric passenger airplane. The Alice, a three-engine, battery-powered airplane that can fly up to 1,000 kilometers on a single charge, will be delivered to Cape Air in 2022.
- Open Access
- 8 February 2011
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 33 (7) , 758-767
Review article: proton pump inhibitors with clopidogrel - evidence for and against a clinically-important interaction
Aliment Pharmacol Ther 2011; 33: 758–767 Summary Background The treatment of acute coronary syndromes involves a combination of antiplatelet therapies. Proton pump inhibitors are frequently recommended for patients receiving clopidogrel in addition to aspirin, to minimise the risk of bleeding. Several studies have shown that proton pump inhibitors can affect the platelet inhibitory effects of clopidogrel. However, the data on whether this has an effect on clinical outcomes are conflicting and a definitive answer is still awaited. Aim To provide an overview of the evidence for the pharmacological interaction between proton pump inhibitors and clopidogrel and to discuss whether this interaction translates into adverse clinical outcomes. Despite recent developments, clear consensus is lacking. Methods A search of the published literature combined with the authors’ knowledge of the field. Results There is evidence to show that proton pump inhibitors can influence the pharmacodynamics of clopidogrel, but the data suggesting clinical effects are weak and conflicting. Supporting a clinically important interaction are four retrospective studies including over 11 000 patients prescribed both clopidogrel and a proton pump inhibitor. Evidence against a clinically important interaction is derived from over 18 000 patients from seven studies, including the only prospective trial to examine the potential interaction. Confounding variables are relevant and prospective clinical evidence is lacking. Conclusions Proton pump inhibitors offer clear protection and the concern over clinically relevant interactions with clopidogrel is biologically plausible, but not yet proven.
- 8 February 2011
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 33 (7) , 758-767
Open AccessReview article: proton pump inhibitors with clopidogrel - evidence for and against a clinically-important interaction
Aliment Pharmacol Ther 2011; 33: 758–767 Summary Background The treatment of acute coronary syndromes involves a combination of antiplatelet therapies. Proton pump inhibitors are frequently recommended for patients receiving clopidogrel in addition to aspirin, to minimise the risk of bleeding. Several studies have shown that proton pump inhibitors can affect the platelet inhibitory effects of clopidogrel. However, the data on whether this has an effect on clinical outcomes are conflicting and a definitive answer is still awaited. Aim To provide an overview of the evidence for the pharmacological interaction between proton pump inhibitors and clopidogrel and to discuss whether this interaction translates into adverse clinical outcomes. Despite recent developments, clear consensus is lacking. Methods A search of the published literature combined with the authors’ knowledge of the field. Results There is evidence to show that proton pump inhibitors can influence the pharmacodynamics of clopidogrel, but the data suggesting clinical effects are weak and conflicting. Supporting a clinically important interaction are four retrospective studies including over 11 000 patients prescribed both clopidogrel and a proton pump inhibitor. Evidence against a clinically important interaction is derived from over 18 000 patients from seven studies, including the only prospective trial to examine the potential interaction. Confounding variables are relevant and prospective clinical evidence is lacking. Conclusions Proton pump inhibitors offer clear protection and the concern over clinically relevant interactions with clopidogrel is biologically plausible, but not yet proven.
- Open Access
Electrochemical Glucose Sensors—Developments Using Electrostatic Assembly and Carbon Nanotubes for Biosensor Construction
In 1962, Clark and Lyons proposed incorporating the enzyme glucose oxidase in the construction of an electrochemical sensor for glucose in blood plasma. In their application, Clark and Lyons describe an electrode in which a membrane permeable to glucose traps a small volume of solution containing the enzyme adjacent to a pH electrode, and the presence of glucose is detected by the change in the electrode potential that occurs when glucose reacts with the enzyme in this volume of solution. Although described nearly 50 years ago, this seminal development provides the general structure for constructing electrochemical glucose sensors that is still used today. Despite the maturity of the field, new developments that explore solutions to the fundamental limitations of electrochemical glucose sensors continue to emerge. Here we discuss two developments of the last 15 years; confining the enzyme and a redox mediator to a very thin molecular films at electrode surfaces by electrostatic assembly, and the use of electrodes modified by carbon nanotubes (CNTs) to leverage the electrocatalytic effect of the CNTs to reduce the oxidation overpotential of the electrode reaction or for the direct electron transport to the enzyme.
Open AccessElectrochemical Glucose Sensors—Developments Using Electrostatic Assembly and Carbon Nanotubes for Biosensor Construction
In 1962, Clark and Lyons proposed incorporating the enzyme glucose oxidase in the construction of an electrochemical sensor for glucose in blood plasma. In their application, Clark and Lyons describe an electrode in which a membrane permeable to glucose traps a small volume of solution containing the enzyme adjacent to a pH electrode, and the presence of glucose is detected by the change in the electrode potential that occurs when glucose reacts with the enzyme in this volume of solution. Although described nearly 50 years ago, this seminal development provides the general structure for constructing electrochemical glucose sensors that is still used today. Despite the maturity of the field, new developments that explore solutions to the fundamental limitations of electrochemical glucose sensors continue to emerge. Here we discuss two developments of the last 15 years; confining the enzyme and a redox mediator to a very thin molecular films at electrode surfaces by electrostatic assembly, and the use of electrodes modified by carbon nanotubes (CNTs) to leverage the electrocatalytic effect of the CNTs to reduce the oxidation overpotential of the electrode reaction or for the direct electron transport to the enzyme.
- 21 October 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 342 (2) , 499-504
Potential driven deposition of polyelectrolytes onto the surface of cysteine monolayers assembled on gold
- 21 October 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 342 (2) , 499-504
Potential driven deposition of polyelectrolytes onto the surface of cysteine monolayers assembled on gold
- 1 August 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 336 (2) , 761-765
Impedance differences found with n-alkanethiol monolayers prepared by contact printing and solution adsorption
- 1 August 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 336 (2) , 761-765
Impedance differences found with n-alkanethiol monolayers prepared by contact printing and solution adsorption
- 1 March 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 331 (2) , 318-321
Electrostatic deposition of polycations and polyanions onto cysteine monolayers
- 1 March 2009
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 331 (2) , 318-321
Electrostatic deposition of polycations and polyanions onto cysteine monolayers
- 24 October 2008
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 24 (22) , 12766-12770
Potential Driven Deposition of Poly(diallyldimethylammonium chloride) onto the Surface of 3-Mercaptopropionic Acid Monolayers Assembled on Gold
Electrochemical impedance spectroscopy (EIS) and quartz crystal microbalance (QCM) measurements are used to examine the ability of applied potential to drive the ionic self-assembly of poly(diallyldimethylammonium) chloride (PDDA) onto a substrate modified with a monolayer of 3-mercaptopropionic acid (3-MPA). The potential of zero charge (PZC) of the gold electrode modified with a monolayer of 3-MPA was found by differential capacitance measurements to be -0.12 (+/-0.01) V versus Ag-AgCl. Changing the substrate potential to values positive (-0.01 V vs Ag-AgCl) of the PZC induces interfacial conditions that are favorable for the electrostatic deposition of cationic polymers onto the surface of 3-MPA monolayers. This result is also consistent with experimental observations obtained when the 3-MPA-modified substrate is exposed to 0.10 mol L (-1) NaOH solutions. When potentials equal or negative to the PZC are applied to the substrate, no significant accumulation of the PDDA is found by either QCM or EIS measurement. This result is consistent with results obtained when the 3-MPA modified substrate is exposed to 0.10 mol L (-1) HCl solutions where no PDDA adsorption is expected because the monolayer is neutral under these conditions. Changes in the impedance and quartz crystal frequency obtained after potential is applied to the substrate are interpreted in terms of the applied potential creating interfacial conditions that are favorable for the deprotonation of the terminal carboxylic acid groups and the subsequent electrostatic assembly of the polycation onto the negatively charged monolayer.
- 24 October 2008
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 24 (22) , 12766-12770
Potential Driven Deposition of Poly(diallyldimethylammonium chloride) onto the Surface of 3-Mercaptopropionic Acid Monolayers Assembled on Gold
Electrochemical impedance spectroscopy (EIS) and quartz crystal microbalance (QCM) measurements are used to examine the ability of applied potential to drive the ionic self-assembly of poly(diallyldimethylammonium) chloride (PDDA) onto a substrate modified with a monolayer of 3-mercaptopropionic acid (3-MPA). The potential of zero charge (PZC) of the gold electrode modified with a monolayer of 3-MPA was found by differential capacitance measurements to be -0.12 (+/-0.01) V versus Ag-AgCl. Changing the substrate potential to values positive (-0.01 V vs Ag-AgCl) of the PZC induces interfacial conditions that are favorable for the electrostatic deposition of cationic polymers onto the surface of 3-MPA monolayers. This result is also consistent with experimental observations obtained when the 3-MPA-modified substrate is exposed to 0.10 mol L (-1) NaOH solutions. When potentials equal or negative to the PZC are applied to the substrate, no significant accumulation of the PDDA is found by either QCM or EIS measurement. This result is consistent with results obtained when the 3-MPA modified substrate is exposed to 0.10 mol L (-1) HCl solutions where no PDDA adsorption is expected because the monolayer is neutral under these conditions. Changes in the impedance and quartz crystal frequency obtained after potential is applied to the substrate are interpreted in terms of the applied potential creating interfacial conditions that are favorable for the deprotonation of the terminal carboxylic acid groups and the subsequent electrostatic assembly of the polycation onto the negatively charged monolayer.